Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Therapeutic Advances in Medical Oncology|November 4, 2014
Treatment strategies for radioactive iodine-refractory differentiated thyroid cancerFrancis WordenEndocrinology and Metabolism Clinics of North America|June 6, 2022
Novel Therapeutics for Advanced Differentiated Thyroid CancerLeedor Lieberman, Francis WordenExpert Review of Anticancer Therapy|December 22, 2018
Sorafenib: key lessons from over 10 years of experienceBernard Escudier, Francis Worden, Masatoshi KudoCancer Investigation|July 2, 2010
A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancersJingsong Zhang, Julia Lee, Susan Urba, et al.Endocrine|December 15, 2023
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United StatesFrancis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, et al.Cancer|July 11, 2013
Marginal treatment benefit in anaplastic thyroid cancerMegan R Haymart, Mousumi Banerjee, Huiying Yin, et al.Ophthalmic Plastic and Reconstructive Surgery|February 13, 2015
Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular AreaHakan Demirci, Francis Worden, Christine C Nelson, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based StudyPalak Choksi, Maria Papaleontiou, Cui Guo, et al.Oral Oncology|January 19, 2021
Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trialPeter Oppelt, Jessica C Ley, Francis Worden, et al.International Journal of Radiation Oncology, Biology, Physics|September 29, 2009
Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancerIris Gluck, Felix Y Feng, Teresa Lyden, et al.Pageof 7